Instil Bio, Inc. (TIL) Insider Trading Activity

NASDAQ$7.075+0.41 (6.15%)
Market Cap
$45.24M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
805 of 849
Rank in Industry
463 of 491

TIL Insider Trading Activity

TIL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Instil Bio, Inc.

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Insider Activity of Instil Bio, Inc.

Over the last 12 months, insiders at Instil Bio, Inc. have bought $0 and sold $0 worth of Instil Bio, Inc. stock.

On average, over the past 5 years, insiders at Instil Bio, Inc. have bought $0 and sold $701,667 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 450,000 shares for transaction amount of $9M was made by Curative Ventures V LLC (10 percent owner) on 2021‑03‑23.

List of Insider Buy and Sell Transactions, Instil Bio, Inc.

2025-09-10SaleLaumas SandeepCFO and CBO
30,000
0.4523%
$23.39
$701,667
-64.58%
2021-03-23PurchaseCurative Ventures V LLC10 percent owner
450,000
5.1249%
$20.00
$9M
-31.22%
2021-03-23PurchaseCrouch BronsonCEO and Chairman
450,000
5.1249%
$20.00
$9M
-31.22%
2021-03-23PurchaseVivo Capital IX, LLC10 percent owner
300,000
3.4166%
$20.00
$6M
-31.22%
2021-03-23PurchaseNielsen Jackdirector
300,000
3.4166%
$20.00
$6M
-31.22%
2021-03-23PurchaseMcGaughy R Kent Jrdirector
450,000
5.1249%
$20.00
$9M
-31.22%
2021-03-23PurchaseShah Nimish Pdirector
300,000
3.4166%
$20.00
$6M
-31.22%
Total: 7

Insider Historical Profitability

<0.0001%
Curative Ventures V LLC10 percent owner
37980073
560.0149%
$253.33M10
<0.0001%
Crouch BronsonCEO and Chairman
37980073
560.0149%
$253.33M10
<0.0001%
Nielsen Jackdirector
12486787
184.1172%
$83.29M10
<0.0001%
Vivo Capital IX, LLC10 percent owner
12486787
184.1172%
$83.29M10
<0.0001%
McGaughy R Kent Jrdirector
8478790
125.0195%
$56.55M10
<0.0001%
Shah Nimish Pdirector
5635937
83.1017%
$37.59M10
<0.0001%

Historical Insider Profitability vs. Competitors

$2,542,362
111
11.81%
$36.83M
$84,911,583
59
17.82%
$37.44M
$693,326
47
-16.24%
$40.24M
$6,204,522
45
1.91%
$36.5M
$24,478,755
37
-34.59%
$53.59M

TIL Institutional Investors: Active Positions

Increased Positions14+28.57%304,490+6.69%
Decreased Positions20-40.82%411,110-9.03%
New Positions7New201,734New
Sold Out Positions12Sold Out357,289Sold Out
Total Postitions43-12.24%4M-2.34%

TIL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Curative Ventures V Llc$21,402.0027.13%1.9M00%2025-09-30
Bml Capital Management, Llc$7,276.009.22%645,600+110,701+20.7%2025-09-30
Cpmg Inc$4,631.005.87%410,92200%2025-09-30
Vivo Capital, Llc$3,299.004.18%292,74300%2025-09-30
Siren, L.L.C.$2,298.002.91%203,93300%2025-09-30
Millennium Management Llc$2,217.002.81%196,742+88,645+82%2025-09-30
Vanguard Group Inc$1,891.002.4%167,810-288-0.17%2025-09-30
Sectoral Asset Management Inc$1,819.002.31%161,380+75,160+87.17%2025-09-30
Morgan Stanley$1,160.001.47%102,938+6,630+6.88%2025-09-30
Dimensional Fund Advisors Lp$911.001.16%80,816-2,006-2.42%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.